Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1275 of 2529 entries
View as:

Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site

Phase: N/A Priority: Normal
NCT ID: NCT02771210 Org: User:
Start: 08/30/16 End: 12/11/19 Due: 12/11/20

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Phase: N/A Priority: Normal
NCT ID: NCT01275196 Org: User:
Start: 04/30/11 End: 10/31/14 Due: 10/31/15

Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan

Phase: N/A Priority: Normal
NCT ID: NCT00742105 Org: User:
Start: 11/17/08 End: 12/22/09 Due: 12/22/10

An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the Brain

Phase: N/A Priority: Normal
NCT ID: NCT05666687 Org: User:
Start: 01/11/23 End: 11/07/23 Due: 11/07/24

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

Phase: N/A Priority: Normal
NCT ID: NCT05750628 Org: User:
Start: 01/23/24 End: 06/19/26 Due: 06/19/27

Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03176238 Org: User:
Start: 03/29/13 End: 01/29/19 Due: 01/29/20

An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Phase: N/A Priority: Normal
NCT ID: NCT01676948 Org: User:
Start: 01/31/13 End: 01/31/15 Due: 01/31/16

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT03060577 Org: User:
Start: 04/27/17 End: 12/17/21 Due: 12/17/22

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01324479 Org: User:
Start: 02/29/12 End: 07/04/17 Due: 07/04/18

A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00658333 Org: User:
Start: 03/31/08 End: 03/31/09 Due: 03/31/10

A Multiple Myeloma Trial in Patients With Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00104104 Org: User:
Start: 10/31/04 End: 10/31/07 Due: 10/31/08

Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01460836 Org: User:
Start: 04/30/10 End: - Due: -

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT03810313 Org: User:
Start: 07/03/19 End: 07/26/21 Due: 07/26/22

Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP)

Phase: N/A Priority: Normal
NCT ID: NCT04630158 Org: User:
Start: 04/21/21 End: 06/08/23 Due: 06/08/24

A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)

Phase: N/A Priority: Normal
NCT ID: NCT04988087 Org: User:
Start: 11/30/21 End: 03/07/23 Due: 03/07/24

Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT00418626 Org: User:
Start: 11/30/06 End: - Due: -

Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema

Phase: N/A Priority: Normal
NCT ID: NCT02366468 Org: User:
Start: 02/23/15 End: 06/08/17 Due: 06/08/18

ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab

Phase: N/A Priority: Normal
NCT ID: NCT02296424 Org: User:
Start: 11/17/14 End: 09/25/17 Due: 09/25/18

Efficacy of LCQ908 on Cardiovascular Risk

Phase: N/A Priority: Normal
NCT ID: NCT01474434 Org: User:
Start: 12/31/11 End: 06/30/14 Due: 06/30/15

Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01874340 Org: User:
Start: 06/30/13 End: 04/30/14 Due: 04/30/15

FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression

Phase: N/A Priority: Normal
NCT ID: NCT02325739 Org: User:
Start: 12/29/14 End: 05/30/19 Due: 05/30/20

Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT00901186 Org: User:
Start: 11/30/09 End: 08/31/12 Due: 08/31/13

Safety and Tolerability of BVS857 in Subjects With Insulin Resistance

Phase: N/A Priority: Normal
NCT ID: NCT01435330 Org: User:
Start: 03/31/11 End: 03/31/12 Due: 03/31/13

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Phase: N/A Priority: Normal
NCT ID: NCT02354508 Org: User:
Start: 03/31/15 End: 09/27/18 Due: 09/27/19

Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00412061 Org: User:
Start: 12/31/06 End: 06/30/13 Due: 06/30/14